Germany's Merck KGgA said on Monday it has agreed to pay Swiss biotech Debiopharm up to 900 million euros ($1.08 billion) to ...

German diversified group Merck KGaA is preparing to put its pigments business up for sale to fund investments at its drugs ...

DARMSTADT, Germany, June 26, 2017 /PRNewswire/. Merck, a leading science and technology company, today announced a collaboration with Elsevier, the information analytics company specializing in ...

Merck boosts its full-year outlook as third-quarter earnings top estimates following strong demand for its blockbuster cancer ...

Yes! I want to get the latest chemistry news from C&EN in my inbox every week. ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly ...

Although Merck (currently trading at $84.57 per share) has gained 7% over the last six months, it has trailed the S&P 500’s 21.3% return during that period. This may have investors wondering how to ...

Q3 earnings beat estimates, but shares dip as 2025 sales outlook narrows. Get key highlights and pharma market insights.

WHITEHOUSE STATION, N.J. & SEOUL, South Korea--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, and Hanwha Chemical Corporation (KOSPI: 09830) today announced ...

PHILADELPHIA, Jan. 1 -- PRWT Services, Inc., a minority-owned business enterprise, today announced that it has, through its wholly-owned subsidiary, Cherokee Pharmaceuticals LLC, acquired the Cherokee ...

The European Commission has approved Merck KGaA’s $17 billion acquisition of Sigma-Aldrich on the condition that the company divest parts of Sigma-Aldrich’s laboratory solvents and inorganic chemicals ...

MRK expects new products like Capvaxive, Winrevair, and the Animal Health business to support its top-line growth in the third quarter.